STAT

Opinion: Price controls would stifle innovation in the pharmaceutical industry

Regulating drug prices might shave a few points off health care spending, but the blow to innovation would be huge.

Consumer access to affordable and effective medicines is an important issue. As the cost of many drugs continues to rise, sometimes astronomically, some have suggested imposing price controls on the U.S. pharmaceutical industry. Doing that risks crippling our only hope of curing the many serious diseases that still plague us.

The global pharmaceutical industry is among the most profitable, driven by its ability to price to value, especially in the United States. High profits attract investors and generate money for research. The global pharmaceutical industry’s investment in on research and development as a percent of sales than do the top 18 U.S. .

You're reading a preview, sign up to read more.

More from STAT

STAT3 min read
Brazilian Lawmakers Propose Compulsory Licensing For Covid-19 Products
Brazil has become the latest country in which some lawmakers are seeking to issue compulsory licenses for medicines and vaccines to combat the novel coronavirus.
STAT4 min readSociety
Opinion: To Restart The Economy, Employers Need To Lead The Way On Covid-19 Testing, Vaccination
Creating a consensus on testing and certification, driven by employers willing and able to take early action, will accelerate America's return to work. No employer in America can afford to…
STAT4 min readSociety
Opinion: Professionalism Drives Health Care Workers To Treat Patients With Covid-19. We Mustn’t Jeopardize It
Americans admire health care workers, and that admiration has justifiably grown during this crisis. But we should realize that the professionalism underneath their work is fragile and needs to be…